Secondary Logo

The Top 100 Articles in Transplantation

Updated:   2/2/2017
Contains:  101 items
Transplantation is the official Journal of The Transplantation Society, and the International Liver Transplantation Society. The journal is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations a year. The journal has been the trusted source for extensive and timely coverage of the most important advances in transplantation. In celebration of the 100th volume of Transplantation, we are pleased to offer you free access to the top 100 articles published in the journal since publication began in 1963. Click on the article titles below to view and download this free content.

STIMULATION OF CD4+ T LYMPHOCYTES BY ALLOGENEIC MHC PEPTIDES PRESENTED ON AUTOLOGOUS ANTIGEN-PRESENTING CELLS: EVIDENCE OF THE INDIRECT PATHWAY OF ALLORECOGNITION IN SOME STRAIN COMBINATIONS

PARKER, KAY E.; DALCHAU, ROSEMARIE; FOWLER, VALERIE J.; More

Transplantation. 53(4):918-924, April 1992.

THE USE OF MYCOPHENOLATE MOFETIL (RS-61443) IN HUMAN HEART TRANSPLANT RECIPIENTS

ENSLEY, R. DOUGLAS; BRISTOW, MICHAEL R.; OLSEN, STEPHANIE L.; More

Transplantation. 56(1):75-81, July 1993.

THE α-1,3-GALACTOSYLTRANSFERASE KNOCKOUT MOUSE: Implications for Xenotransplantation1

Tearle, Rick G.; Tange, Margaret J.; Zannettino, Zara L.; More

Transplantation. 61(1):13-19, January 15th, 1996.

PROPHYLACTIC ORAL GANCICLOVIR COMPARED WITH DEFERRED THERAPY FOR CONTROL OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS1,2,†

Brennan, Daniel C.; Garlock, Kathy A.; Singer, Gary G.; More

Transplantation. 64(12):1843-1846, December 27th, 1997.

A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VERSUS ATGAM FOR INDUCTION IMMUNOSUPPRESSIVE THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS1,2

Brennan, Daniel C.; Flavin, Karen; Lowell, Jeffrey A.; More

Transplantation. 67(7):1011-1018, April 15th, 1999.

Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors1

Port, Friedrich K.; Bragg-Gresham, Jennifer L.; Metzger, Robert A.; More

Transplantation. 74(9):1281-1286, November 15th, 2002.

RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)

Kirk, Allan D.; Hale, Douglas A.; Mannon, Roslyn B.; More

Transplantation. 76(1):120-129, July 15th, 2003.

Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations

Hirsch, Hans H.; Brennan, Daniel C.; Drachenberg, Cinthia B.; More

Transplantation. 79(10):1277-1286, May 27th, 2005.

Corticosteroid-Free Immunosuppression with Tacrolimus, Mycophenolate Mofetil, and Daclizumab Induction in Renal Transplantation

Rostaing, Lionel; Cantarovich, Diego; Mourad, Georges; More

Transplantation. 79(7):807-814, April 15th, 2005.

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

Ringdén, Olle; Uzunel, Mehmet; Rasmusson, Ida; More

Transplantation. 81(10):1390-1397, May 27th, 2006.

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

Everly, Matthew J.; Everly, Jason J.; Susskind, Brian; More

Transplantation. 86(12):1754-1761, December 27th, 2008.

Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

Schena, Francesco P.; Pascoe, Michael D.; Alberu, Josefina; More

Transplantation. 87(2):233-242, January 27th, 2009.

Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts

Lachmann, Nils; Terasaki, Paul I.; Budde, Klemens; More

Transplantation. 87(10):1505-1513, May 27th, 2009.

High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation

Ciurea, Stefan O.; de Lima, Marcos; Cano, Pedro; More

Transplantation. 88(8):1019-1024, October 27th, 2009.

Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure

Gaston, Robert S.; Cecka, J. Michael; Kasiske, Bert L.; More

Transplantation. 90(1):68-74, July 15th, 2010.

Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ Transplantation

Dew, Mary Amanda; DiMartini, Andrea F.; De Vito Dabbs, Annette; More

Transplantation. 83(7):858-873, April 15th, 2007.

Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

Alberú, Josefina; Pascoe, Michael D.; Campistol, Josep M.; More

Transplantation. 92(3):303-310, August 15th, 2011.

Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

Tait, Brian D.; Süsal, Caner; Gebel, Howard M.; More

Transplantation Journal. 95(1):19-47, January 15th, 2013.

Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

Kotton, Camille N.; Kumar, Deepali; Caliendo, Angela M.; More

Transplantation Journal. 96(4):333-360, August 27th, 2013.

Show: